0001415889-22-004542.txt : 20220503 0001415889-22-004542.hdr.sgml : 20220503 20220503171046 ACCESSION NUMBER: 0001415889-22-004542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220502 FILED AS OF DATE: 20220503 DATE AS OF CHANGE: 20220503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adler Reid G. CENTRAL INDEX KEY: 0001924908 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 22888214 MAIL ADDRESS: STREET 1: C/O VISTAGEN THERAPEUTICS, INC. STREET 2: 343 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 4 1 form4-05032022_020513.xml X0306 4 2022-05-02 0001411685 VistaGen Therapeutics, Inc. VTGN 0001924908 Adler Reid G. C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false CHIEF LEGAL OFFICER Stock Options (right to buy) 1.28 2022-05-02 4 A 0 200000 0 A 2032-05-02 Common Stock 200000 200000 D 25% of the stock options vest on May 2, 2023 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. /s/ Jerrold D. Doston, Attorney-in-Fact 2022-05-03